Free Trial

Drugs Made In America Acquisition (DMAA) Competitors

$10.31 +0.01 (+0.10%)
As of 10/23/2025 01:28 PM Eastern

DMAA vs. SAFE, ORC, IPXX, DEA, CSR, SBR, GETY, PLYM, PAX, and FBRT

Should you be buying Drugs Made In America Acquisition stock or one of its competitors? The main competitors of Drugs Made In America Acquisition include Safehold (SAFE), Orchid Island Capital (ORC), Inflection Point Acquisition Corp. II (IPXX), Easterly Government Properties (DEA), Centerspace (CSR), Sabine Royalty Trust (SBR), Getty Images (GETY), Plymouth Industrial REIT (PLYM), Patria Investments (PAX), and Franklin BSP Realty Trust (FBRT). These companies are all part of the "trading" industry.

Drugs Made In America Acquisition vs. Its Competitors

Drugs Made In America Acquisition (NASDAQ:DMAA) and Safehold (NYSE:SAFE) are both small-cap trading companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, dividends, valuation, analyst recommendations, media sentiment, earnings, risk and institutional ownership.

Safehold has higher revenue and earnings than Drugs Made In America Acquisition.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Drugs Made In America AcquisitionN/AN/AN/AN/AN/A
Safehold$365.68M3.05$105.76M$1.4310.86

In the previous week, Safehold had 5 more articles in the media than Drugs Made In America Acquisition. MarketBeat recorded 5 mentions for Safehold and 0 mentions for Drugs Made In America Acquisition. Safehold's average media sentiment score of 0.62 beat Drugs Made In America Acquisition's score of 0.00 indicating that Safehold is being referred to more favorably in the news media.

Company Overall Sentiment
Drugs Made In America Acquisition Neutral
Safehold Positive

Safehold has a net margin of 27.45% compared to Drugs Made In America Acquisition's net margin of 0.00%. Safehold's return on equity of 4.70% beat Drugs Made In America Acquisition's return on equity.

Company Net Margins Return on Equity Return on Assets
Drugs Made In America AcquisitionN/A N/A N/A
Safehold 27.45%4.70%1.61%

70.4% of Safehold shares are held by institutional investors. 3.5% of Safehold shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Safehold has a consensus target price of $19.89, suggesting a potential upside of 28.03%. Given Safehold's stronger consensus rating and higher probable upside, analysts clearly believe Safehold is more favorable than Drugs Made In America Acquisition.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Drugs Made In America Acquisition
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Safehold
0 Sell rating(s)
7 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.30

Summary

Safehold beats Drugs Made In America Acquisition on 11 of the 11 factors compared between the two stocks.

Get Drugs Made In America Acquisition News Delivered to You Automatically

Sign up to receive the latest news and ratings for DMAA and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding DMAA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

DMAA vs. The Competition

MetricDrugs Made In America AcquisitionInvestment Offices IndustryFinancial SectorNASDAQ Exchange
Market Cap$300.47M$281.92M$4.86B$10.57B
Dividend YieldN/AN/A4.41%4.83%
P/E RatioN/AN/A22.5328.46
Price / SalesN/AN/A1,453.37188.31
Price / CashN/A18,601.67127.7460.64
Price / BookN/AN/A2.146.53
Net IncomeN/A$12.92M$1.22B$276.75M
7 Day Performance0.10%0.01%0.47%0.93%
1 Month PerformanceN/A1.78%0.53%1.41%
1 Year PerformanceN/A5.88%38.75%31.59%

Drugs Made In America Acquisition Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
DMAA
Drugs Made In America Acquisition
N/A$10.31
+0.1%
N/AN/A$300.47MN/A0.002
SAFE
Safehold
4.2986 of 5 stars
$15.45
-0.8%
$19.89
+28.7%
-33.5%$1.12B$365.68M10.80120Upcoming Earnings
ORC
Orchid Island Capital
2.7747 of 5 stars
$7.31
+0.7%
N/A-4.6%$1.06B$241.58M36.552,018News Coverage
Earnings Report
Short Interest ↑
IPXX
Inflection Point Acquisition Corp. II
N/A$33.68
-10.3%
N/A+126.9%$1.05BN/A0.00N/AGap Down
High Trading Volume
DEA
Easterly Government Properties
3.758 of 5 stars
$22.01
-2.4%
$26.41
+20.0%
-35.6%$1.02B$302.05M53.6850Upcoming Earnings
Dividend Announcement
CSR
Centerspace
3.218 of 5 stars
$60.71
+1.4%
$68.00
+12.0%
-15.7%$1.00B$260.98M-33.73470News Coverage
Positive News
SBR
Sabine Royalty Trust
1.7899 of 5 stars
$67.26
-1.0%
N/A+15.4%$990.38M$83.17M13.352,020News Coverage
GETY
Getty Images
3.0742 of 5 stars
$2.18
-7.6%
$4.03
+84.6%
-44.7%$978.96M$939.29M-7.791,700
PLYM
Plymouth Industrial REIT
2.4491 of 5 stars
$22.03
+0.5%
$21.33
-3.2%
+3.8%$977.07M$198.35M7.6540News Coverage
Analyst Downgrade
PAX
Patria Investments
2.3292 of 5 stars
$14.34
-2.0%
$14.00
-2.4%
+31.1%$953.93M$397.39M28.68390
FBRT
Franklin BSP Realty Trust
3.801 of 5 stars
$10.63
-0.3%
$14.67
+38.0%
-16.7%$877.05M$516.24M10.85N/APositive News
Upcoming Earnings

Related Companies and Tools


This page (NASDAQ:DMAA) was last updated on 10/24/2025 by MarketBeat.com Staff
From Our Partners